1. Home
  2. VYGR vs ACR Comparison

VYGR vs ACR Comparison

Compare VYGR & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ACR
  • Stock Information
  • Founded
  • VYGR 2013
  • ACR 2005
  • Country
  • VYGR United States
  • ACR United States
  • Employees
  • VYGR N/A
  • ACR N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • VYGR Health Care
  • ACR Real Estate
  • Exchange
  • VYGR Nasdaq
  • ACR Nasdaq
  • Market Cap
  • VYGR 191.9M
  • ACR 154.7M
  • IPO Year
  • VYGR 2015
  • ACR N/A
  • Fundamental
  • Price
  • VYGR $3.17
  • ACR $18.41
  • Analyst Decision
  • VYGR Strong Buy
  • ACR Buy
  • Analyst Count
  • VYGR 9
  • ACR 2
  • Target Price
  • VYGR $14.86
  • ACR $17.50
  • AVG Volume (30 Days)
  • VYGR 282.0K
  • ACR 31.8K
  • Earning Date
  • VYGR 05-06-2025
  • ACR 04-30-2025
  • Dividend Yield
  • VYGR N/A
  • ACR N/A
  • EPS Growth
  • VYGR N/A
  • ACR N/A
  • EPS
  • VYGR N/A
  • ACR 0.34
  • Revenue
  • VYGR $66,958,000.00
  • ACR $83,545,000.00
  • Revenue This Year
  • VYGR N/A
  • ACR $8.36
  • Revenue Next Year
  • VYGR $2.04
  • ACR N/A
  • P/E Ratio
  • VYGR N/A
  • ACR $54.27
  • Revenue Growth
  • VYGR N/A
  • ACR 6.92
  • 52 Week Low
  • VYGR $2.75
  • ACR $12.33
  • 52 Week High
  • VYGR $9.55
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 40.49
  • ACR 46.30
  • Support Level
  • VYGR $3.46
  • ACR $18.30
  • Resistance Level
  • VYGR $3.69
  • ACR $19.10
  • Average True Range (ATR)
  • VYGR 0.18
  • ACR 0.79
  • MACD
  • VYGR 0.00
  • ACR 0.13
  • Stochastic Oscillator
  • VYGR 0.00
  • ACR 52.44

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: